Latest Advances

  • Condition: Giant Cell Arteritis (GCA)
  • Journal: Arthritis research & therapy
  • Treatment Used: Tocilizumab (TCZ)
  • Number of Patients: 186
  • Published —
This study analyzed the occurrence of vision loss in patients with giant cell arteritis (GCA) treated with tocilizumab (TCZ).
  • Condition: Giant Cell Arteritis
  • Journal: Arthritis research & therapy
  • Treatment Used: Tocilizumab
  • Number of Patients: 60
  • Published —
In this study, researchers evaluated the safety and effectiveness of tocilizumab for the treatment of giant cell arteritis.
  • Condition: Giant Cell Arteritis
  • Journal: International journal of clinical pharmacology and therapeutics
  • Treatment Used: Biological Agents
  • Number of Patients: 453
  • Published —
In this study, researchers evaluated the safety and effectiveness of biological agents for the treatment of giant cell arteritis.
  • Condition: Giant Cell Arteritis
  • Journal: Clinical and experimental rheumatology
  • Treatment Used: Tocilizumab
  • Number of Patients: 385
  • Published —
The study researched the outcomes of tocilizumab for treating giant cell arteritis.
  • Condition: Giant Cell Arteritis
  • Journal: Clinical and experimental rheumatology
  • Treatment Used: Tocilizumab
  • Number of Patients: 1
  • Published —
This case report describes a patient that developed intracranial vasculitis during their treatment of giant cell arteritis with tocilizumab.
  • Condition: Giant Cell Arteritis (GCA)
  • Journal: Current opinion in rheumatology
  • Treatment Used: Tocilizumab
  • Number of Patients: 0
  • Published —
This article addresses new development in the diagnosis and management of giant cell arteritis (GCA).
  • Condition: Eosinophilic Temporal Arteritis and Digital Ischemia in a Patient with Hypereosinophilic Syndrome
  • Journal: Internal medicine (Tokyo, Japan)
  • Treatment Used: Low-dose corticosteroid
  • Number of Patients: 0
  • Published —
The study researched the outcomes of eosinophilic temporal arteritis and digital ischemia in a patient with hypereosinophilic syndrome.
  • Condition: Large Vessel Vasculitis
  • Journal: Rheumatology (Oxford, England)
  • Treatment Used: Tocilizumab
  • Number of Patients: 12
  • Published —
This study evaluated the effectiveness and safety of tocilizumab therpay for large vessel vasculitis.
  • Condition: Aortitis Disease
  • Journal: The heart surgery forum
  • Treatment Used: Aortic Valve Surgery
  • Number of Patients: 15
  • Published —
The study researched the outcomes of aortic valve surgery in patients with aortitis disease.
  • Condition: Glucocorticoid Resistant Refractory Giant Cell Arteritis
  • Journal: BMJ case reports
  • Treatment Used: intravenous tocilizumab
  • Number of Patients: 1
  • Published —
The purpose of the study was to report a case of a patient with glucocorticoid resistant refractory giant cell arteritis treated with intravenous tocilizumab.
  • Condition: Large-vessel vasculitis giant cell arteritis (GCA) and Takayasu arteritis (TA)
  • Journal: Der Internist
  • Treatment Used: Tocilizumab (TCZ)
  • Number of Patients: 0
  • Published —
This study described the necessary diagnostic testing and rapid treatment approaches for patients diagnosed with large-vessel vasculitis -- giant cell arteritis (GCA) and Takayasu arteritis (TA) --
  • Condition: Giant Cell Arteritis
  • Journal: International journal of rheumatic diseases
  • Treatment Used: Glucocorticoid Therapy
  • Number of Patients: 14
  • Published —
This study tested the safety and efficacy of using glucocorticoid therapy to treat patients with giant cell arteritis.
Showing 1-12 of 20